Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS).
Santos E, Clark C, Biag HMB, Tang SJ, Kim K, Ponzini MD, Schneider A, Giulivi C, Montanaro FAM, Gipe JT, Dayton J, Randol JL, Yao PJ, Manolopoulos A, Kapogiannis D, Hwang YH, Hagerman P, Hagerman R, Tassone F.
Santos E, et al. Among authors: hwang yh.
Cells. 2023 Dec 5;12(24):2773. doi: 10.3390/cells12242773.
Cells. 2023.
PMID: 38132093
Free PMC article.